Skip to main content
Premium Trial:

Request an Annual Quote

Premier Biosoft Buys Redasoft to Expand Life Science Customer Base

Premium

Premier Biosoft has acquired privately held bioinformatics company Redasoft in an effort to expand its life sciences software business.

Redasoft markets sequence analysis software dubbed Visual Cloning, which includes vector map drawing capabilities and lets users create graphical maps based on sequence data. It also provides tools for restriction site analysis as well as to search for open reading frames.

Palo Alto, Calif.-based Premier, which is also privately held, expects the new acquisition to expand its reach in the life science software market.

“The acquisition of Redasoft demonstrates our strategy to strengthen our presence in the life science sector and deliver sustainable ... growth by offering a wide portfolio of products and services,” Kay Brown, Premier's president, said in a statement.

Premier offers software products and services for PCR and real time PCR, cloning, DNA and tissue microarrays, suspension bead arrays, glycomics, and mutagenesis. Its primary customers are government agencies, pharmaceutical and biotechnology companies, and academic researchers.

Additional details about the acquisition were not provided.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.